GlassScriptPhysician profile
Steven C Chudik
NPI 1215029210
$4,058,043.58
in general payments reported to CMS, 2019-2025
14 companies · $83K in 2025
The $83K reported for 2025 was more than what 96% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $613K · 2020: $813K · 2021: $111K · 2022: $838 · 2023: $2.4M · 2024: $29K · 2025: $83K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $2.5M · Consulting Fee: $61K · Travel and Lodging: $3,284 · Food and Beverage: $734.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $2,455,890.18 |
| Consulting Fee | $60,577.52 |
| Travel and Lodging | $3,284.34 |
| Food and Beverage | $733.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $3,987,591.60 | 2019-2025 | Arthrex |
| Depuy Synthes Products, INC. | $54,068.53 | 2022-2025 | Inhance, Reclaim |
| Medical Device Business Services, INC. | $10,526.47 | 2022-2025 | Inhance |
| Medwest Associates | $3,308.21 | 2019-2021 | |
| Exactech, INC. | $1,424.02 | 2019 | |
| Wright Medical Technology, INC. | $724.17 | 2019-2020 | |
| Depuy Synthes Sales INC. | $189.31 | 2021-2025 | Inhance |
| Zimmer Biomet Holdings, INC. | $68.73 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $45.13 | 2021 | |
| Solventum Corporation | $35.38 | 2024 | Prevena |
| Orthofix Medical, INC. | $30.18 | 2024 | Physio-Stim |
| Heron Therapeutics, INC. | $16.02 | 2023 | Zynrelef |
| Ethicon US, LLC | $15.83 | 2022 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$100,000.18 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Chudik listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.